Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-03-31 | Edward L. Kuntz, 69 joined the Board of Directors in September 2013. Mr. Kuntz has served as Chairman of Kindred Healthcare, Inc. (NYSE: KND), one of the largest providers of long-term health care services in the United States, since May 2009. He served as the Executive Chairman of Kindred from January 2004 to May 2009 and as Kindred’s Chairman and Chief Executive Officer from January 1999 to December 31, 2003. Mr. Kuntz is a director of Rotech Healthcare, Inc., one of the largest providers of home medical equipment and related products and services in the United States, where he serves as a member of the audit and operating committees. He is also a senior operating partner with Sentinel Capital Partners, a New York-based private equity firm where he serves on a number of portfolio company boards and an advisory partner of Aperture Venture Partners and Woodway Financial Advisors. Mr. Kuntz previously served as CEO of Kindred from 1999-2003 and as a director of PharMerica. The Board believes that Mr. Kuntz’s experience as an executive and director of a variety of growing public and private equity-backed companies brings valuable experience to the board in matters such as organizational structure, corporate strategy, operational performance measurement and improvement and governance. The members of the Audit Committee are currently Peter Menikoff (Chairman), Casey Crenshaw, Neal M. Dikeman and Edward L. Kuntz. The members of the Corporate Governance and Nominating Committee are currently J. Hoke Peacock, II (Chairman), Peter Menikoff, Neal M. Dikeman, Casey Crenshaw and Edward L. Kuntz. The members of the Compensation Committee are currently Casey Crenshaw (Chairman), J. Hoke Peacock, II, Neal M. Dikeman, Peter Menikoff and Edward L. Kuntz. The following table provides information regarding compensation earned by, awarded or paid to non-employee directors who served during the year ended December 31, 2013. Edward L. Kuntz received $5,750 in total compensation. |
| 2015-03-30 | Edward L. Kuntz, 70 joined the Board of Directors in September 2013. Mr. Kuntz has served as Chairman of Kindred Healthcare, Inc. (NYSE: KND), one of the largest providers of long-term health care services in the United States, from May 2009 until May 2014, when he did not run for reelection. He served as the Executive Chairman of Kindred from January 2004 to May 2009 and as Kindred’s Chairman and Chief Executive Officer from January 1999 to December 31, 2003. Mr. Kuntz is a director of Rotech Healthcare, Inc., one of the largest providers of home medical equipment and related products and services in the United States, where he serves as a member of the audit and operating committees. He has been on the Board of Directors of U.S. Physical Therapy Inc. since August 2014. He is also a senior operating partner with Sentinel Capital Partners, a New York-based private equity firm where he serves on a number of portfolio company boards and an advisory partner of Aperture Venture Partners and Woodway Financial Advisors. Mr. Kuntz previously served as CEO of Kindred from 1999-2003 and as a director of PharMerica. The Board believes that Mr. Kuntz’s experience as an executive and director of a variety of growing public and private equity-backed companies brings valuable experience to the board in matters such as organizational structure, corporate strategy, operational performance measurement and improvement and governance. The members of the Audit Committee are currently Edward L. Kuntz (Chairman), Peter Menikoff , Casey Crenshaw and Neal M. Dikeman. The Audit Committee met five (one was telephonic) times during the fiscal year ended December 31, 2014. The Board has determined that Messrs. Menikoff, Crenshaw, Dikeman and Kuntz are “independent” as defined in the listing standards of the NASDAQ Stock Market and that Mr. Menikoff, Mr.Dikeman and Mr.Kuntz qualify as “audit committee financial experts” as defined in the regulations of the Securities and Exchange Commission. The members of the Corporate Governance and Nominating Committee are currently J. Hoke Peacock, II (Chairman), Peter Menikoff, Neal M. Dikeman, Casey Crenshaw and Edward L. Kuntz. The Board of Directors determined that Messrs. Peacock, Menikoff, Dikeman, Crenshaw and Kuntz are considered independent as defined in the listing standards of the NASDAQ Stock Market. The members of the Compensation Committee are currently Neal M. Dikeman (Chairman), Casey Crenshaw, J. Hoke Peacock, II, Peter Menikoff and Edward L. Kuntz. The Board of Directors determined that Messrs. Crenshaw, Peacock, Dikeman, Menikoff and Kuntz are considered independent as defined in the listing standards of the NASDAQ Stock Market. The following table provides information regarding compensation earned by, awarded or paid to directors who served during the year ended December 31, 2014. Edward L. Kuntz Fees Earned or Paid in Cash: 50,000 Total: 50,000. |
| 2016-03-29 | Edward L. Kuntz, 71 joined the Board of Directors in September 2013. Mr. Kuntz has served as Chairman of Kindred Healthcare, Inc. (NYSE: KND), one of the largest providers of long-term health care services in the United States, from May 2009 until May 2014, when he did not run for reelection. He served as the Executive Chairman of Kindred from January 2004 to May 2009 and as Kindred’s Chairman and Chief Executive Officer from January 1999 to December 31, 2003. Mr. Kuntz is a director of Rotech Healthcare, Inc., one of the largest providers of home medical equipment and related products and services in the United States, where he serves as a member of the audit and operating committees. He has been on the Board of Directors of U.S. Physical Therapy Inc. since August 2014. He is also a senior operating partner with Sentinel Capital Partners, a New York-based private equity firm where he serves on a number of portfolio company boards and an advisory partner of Aperture Venture Partners and Woodway Financial Advisors. Mr. Kuntz previously served as CEO of Kindred from 1999-2003 and as a director of PharMerica. The Board believes that Mr. Kuntz’s experience as an executive and director of a variety of growing public and private equity-backed companies brings valuable experience to the board in matters such as organizational structure, corporate strategy, operational performance measurement and improvement and governance. The members of the Audit Committee are currently Edward L. Kuntz (Chairman), Peter Menikoff , Casey Crenshaw and Neal M. Dikeman. The Audit Committee met four times during the fiscal year ended December 31, 2015. The Board has determined that Messrs. Menikoff, Crenshaw, Dikeman and Kuntz are “independent” as defined in the listing standards of the NASDAQ Stock Market and that Mr. Menikoff, Mr.Dikeman and Mr.Kuntz qualify as “audit committee financial experts” as defined in the regulations of the Securities and Exchange Commission. The members of the Corporate Governance and Nominating Committee are currently J. Hoke Peacock, II (Chairman), Peter Menikoff, Neal M. Dikeman, Casey Crenshaw and Edward L. Kuntz. The Board of Directors determined that Messrs. Peacock, Menikoff, Dikeman, Crenshaw and Kuntz are considered independent as defined in the listing standards of the NASDAQ Stock Market. The members of the Compensation Committee are currently Neal M. Dikeman (Chairman), Casey Crenshaw, J. Hoke Peacock, II, Peter Menikoff and Edward L. Kuntz. The Board of Directors determined that Messrs. Crenshaw, Peacock, Dikeman, Menikoff and Kuntz are considered independent as defined in the listing standards of the NASDAQ Stock Market. The following table provides information regarding compensation earned by, awarded or paid to directors who served during the year ended December 31, 2015. Edward L. Kuntz Fees Earned or Paid in Cash $50,000. |
| 2017-03-27 | Edward L. Kuntz, 72 joined the Board of Directors in September 2013... The members of the Audit Committee are currently Edward L. Kuntz (Chairman), Peter Menikoff , Casey Crenshaw and Neal M. Dikeman... The members of the Corporate Governance and Nominating Committee are currently J. Hoke Peacock, II (Chairman), Peter Menikoff, Neal M. Dikeman, Casey Crenshaw and Edward L. Kuntz... The members of the Compensation Committee are currently Neal M. Dikeman (Chairman), Casey Crenshaw, J. Hoke Peacock, II, Peter Menikoff and Edward L. Kuntz... 2016 Director Compensation table shows Edward L. Kuntz total compensation of $48,250. |
| 2018-04-23 | Edward L. Kuntz, 73 joined the Board of Directors in September 2013. Mr. Kuntz has served as Chairman of Kindred Healthcare, Inc. (NYSE: KND), one of the largest providers of long-term health care services in the United States, from May 2009 until May 2014, when he did not run for reelection. |
| 2020-08-03 | Edward L. Kuntz, age 75, was appointed to the Board of Directors of Stabilis on July 26, 2019. He served on the Board of Directors and as Chairman of the Audit Committee of American Electric from September 2013 to July 2019. Mr. Kuntz currently serves as the Chairman of the Board of Directors of U.S Physical Therapy, Inc., a publicly held operator of physical therapy clinics and related businesses. He has been a director since 2014. Mr. Kuntz is the former Chairman and Chief Executive Officer of Kindred Healthcare, the largest diversified provider of post-acute care services in the United States. From 1998 through May 2014 he served as Chairman of the Board of Directors of Kindred and as Chief Executive Officer from 1998 to 2004. From 2000 through 2016, Mr. Kuntz served as a director of Rotech Healthcare, Inc., one of the largest providers of home medical equipment and related products and services in the United States. Mr. Kuntz received B.A., J.D. and L.L.M. degrees from Temple University. The Board believes that Mr. Kuntz’s experience as an executive and director of a variety of growing public and private equity-backed companies brings valuable experience to the Board in matters such as organizational structure, corporate strategy, operational performance measurement and improvement and governance. The members of the Compensation Committee are currently J. Casey Crenshaw (Chairman), Peter C. Mitchell, Mushahid Khan, and Edward L. Kuntz. The Board of Directors determined that Messrs. Mitchell, Khan, and Kuntz are considered independent as defined in the rules of the OTCQX Best Market. The members of the Audit Committee are currently Peter C. Mitchell (Chairman), Mushahid Khan, and Edward L. Kuntz. Following the completion of the Share Exchange with AETI on July 26, 2019, the Audit Committee met two times during the fiscal year ended December 31, 2019. The Board has determined that Messrs. Mitchell, Khan, and Kuntz are “independent” as defined in the rules of the OTCQX Best Market and that Messrs. Mitchell and Kuntz each qualify as an “audit committee financial expert” as defined in the regulations of the Securities and Exchange Commission. The Company has established the following compensation for its independent directors: i.Cash compensation of $50,000 per annum payable quarterly; and ii. Equity compensation of $50,000 of Company common stock per annum calculated based on the market price of the Company’s common stock as of the close of business immediately prior to the first Board of Directors meeting in each calendar year with vesting one year later. The Company pays each director’s reasonable travel, lodging, meals and other expenses connected with their Board service. Directors who are not independent receive no separate compensation for director service. The following table describes the compensation earned following the completion of the Share Exchange on July 26, 2019 by each individual who served as a non-employee director during 2019. Edward L. Kuntz received $25,000 in fees earned or paid in cash and $25,000 in stock awards for a total of $50,000. |
| 2021-08-02 | The members of the Audit Committee are currently Peter C. Mitchell (Chairman), Mushahid Khan, and Edward L. Kuntz. The members of the Compensation Committee are currently J. Casey Crenshaw (Chairman), Peter C. Mitchell, Mushahid Khan, and Edward L. Kuntz. The following table describes the compensation earned by each individual who served as an independent director during 2020. Edward L. Kuntz $50,000 cash and $50,000 stock awards totaling $100,000. |
| 2022-07-01 | The members of the Audit Committee are currently Peter C. Mitchell (Chairman), Matthew W. Morris, and Edward L. Kuntz. The members of the Compensation Committee are currently J. Casey Crenshaw (Chairman), Peter C. Mitchell, Matthew W. Morris, and Edward L. Kuntz. For 2021, the Board has established cash compensation for its independent directors at $100,000 per annum payable quarterly. Edward L. Kuntz total compensation $100,000. |
| 2023-06-28 | The members of the Audit Committee are currently Peter C. Mitchell (Chairman), Matthew W. Morris, and Edward L. Kuntz. The members of the Compensation Committee are currently J. Casey Crenshaw (Chairman), Peter C. Mitchell, Matthew W. Morris, and Edward L. Kuntz. For 2022, the Board has established cash compensation for its independent directors at $100,000 per annum payable quarterly. Directors who are not independent receive no separate compensation for director service. The Company pays each director’s reasonable travel, lodging, meals and other expenses connected with their Board service. 2022 Director Compensation: Edward L. Kuntz $100,000 total. |
| 2024-06-28 | The members of the Audit Committee are currently Peter C. Mitchell (Chairman), Matthew W. Morris, and Edward L. Kuntz. The members of the Compensation Committee are currently J. Casey Crenshaw (Chairman), Peter C. Mitchell, Matthew W. Morris, and Edward L. Kuntz. For 2023, the Board has established cash compensation for its independent directors at $100,000 per annum payable quarterly. |
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-09 | Edward L. Kuntz has served on our Board since August 26, 2014. ... The Compliance Committee consists of five independent directors. The current members of the committee are Messrs. Kuntz (effective December 9, 2014)(Chairman), Brookner, Chapman, Johnston, and Dr. Harris, all of whom have been determined to be independent, as defined in the NYSE listing standards. ... The Audit Committee currently consists of Messrs. Trier (Chairman), Brookner, Harris, Johnston and Pullins. ... The Chairman of the committee is Messrs. Kuntz (effective December 9, 2014)(Chairman). ... The Audit Committee currently consists of Messrs. Trier (Chairman), Brookner, Harris, Johnston and Pullins. ... The Chairman of the Audit Committee is paid an annual fee of $18,000, the Chairman of the Compensation Committee is paid an annual fee $12,000, and the Chairman of the Compliance Committee is paid an annual fee of $10,000. ... During 2014, each of our non-employee directors received $10,000 per quarter (Retainer Fee) for serving as a member of our Board of Directors. ... The following table discloses the cash, equity awards and other compensation earned, paid or awarded, as the case may be, to each of the Company’s directors who are not Named Executive Officers during the fiscal year ended December 31, 2014. ... Edward L. Kuntz $13,333 Fees Earned in Cash, $107,970 Stock Awards, Total $121,303. |
| 2016-04-07 | Edward L. Kuntz has served on our Board since August 26, 2014. ... The Compliance Committee consists of five independent directors. The current members of the committee are Messrs. Kuntz (Chairman), Brookner, Chapman, Johnston, and Dr. Harris ... Director Compensation Table ... Edward L. Kuntz. $55,500 fees earned or paid in cash, $136,043 stock awards, total $191,543. |
| 2017-08-15 | Edward L. Kuntz has served on our Board since August 26, 2014. ... The Compliance Committee currently consists of five independent directors. The current members of the committee are Messrs. Kuntz (Chairman), Brookner, Chapman, Harris and Johnston. ... Director Compensation Table ... Edward L. Kuntz $55,750 Fees Earned in Cash, $140,225 Stock Awards, Total $195,975. |
| 2018-04-05 | Edward L. Kuntz has served on our Board since August 26, 2014. ... The Compliance Committee currently consists of four independent directors. The current members of the committee are Messrs. Kuntz (Chairman), Brookner, Chapman, and Harris ... The current members of the Compensation Committee are Messrs. Chapman (Chairman), Pullins and Kuntz ... Edward L. Kuntz. $57,000 Fees Earned or Paid in Cash, $125,600 Stock Awards, Total $182,600. |
| 2019-04-05 | Edward L. Kuntz has served on our Board since August 26, 2014. ... The Compliance Committee currently consists of five independent directors. The current members of the committee are Mr. Kuntz (Chairman), Mr. Brookner, Mr. Chapman, Dr. Harris and Ms. Gilmartin ... The current members of the Compensation Committee are Messrs. Chapman (Chairman), Pullins and Kuntz ... Edward L. Kuntz total compensation $266,450. |
| 2020-06-26 | Edward L. Kuntz has served on our Board since August 26, 2014, and as Chairman effective as of May 19, 2020. Mr. Kuntz is the former Chairman and Chief Executive Officer of Kindred Healthcare... Mr. Kuntz also serves as a director of Stablis Energy, Inc., a supplier and distributor of liquified natural gas and is on its Audit and Compensation committees. |
| 2021-04-05 | Mr. Kuntz has served on our Board since August 26, 2014, and as Chairman since May 19, 2020. Mr. Kuntz is the former Chairman and Chief Executive Officer of Kindred Healthcare... Chairman of the Governance and Nominating Committee... The current members of the Compensation Committee are Mr. Chapman (Chairman), Ms. Gilmartin and Mr. Kuntz... Director Compensation Table shows total $228,479 for Mr. Kuntz. |
| 2022-04-04 | Mr. Kuntz has served as Chairman of our Board since May 19, 2020. Mr. Kuntz is the former Chairman and Chief Executive Officer of Kindred Healthcare. He is Chairman of the Governance and Nominating Committee. Director Compensation Table shows total compensation of $327,479. |
| 2023-04-10 | Mr. Kuntz has served as Chairman of our Board since May 19, 2020. Mr. Kuntz is the former Chairman and Chief Executive Officer of Kindred Healthcare. He is Chairman of the Governance and Nominating Committee. Director Compensation Table shows total compensation of $318,712. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22